Changmao Biochemical Engineering

Changmao Biochemical Engineering, founded in 1992, is a specialized manufacturer operating within the chemicals and petrochemicals sector. The company focuses on the production of C-4 series organic acids and their corresponding salts, maintaining an annual production volume exceeding 30,000 tons. Their core product portfolio includes L-malic acid, DL-malic acid, L(+)-tartaric acid, DL-tartaric acid, fumaric acid, aspartame, L-alanine, DL-potassium bitartrate, and cream of tartar. These biochemical compounds serve critical roles in the global food, pharmaceutical, and chemical industries.

The organization maintains a robust operational footprint with 500-1,000 employees and a single primary production facility. Changmao Biochemical Engineering demonstrates significant international market penetration, with over 70% of its total production volume exported to key regions including Japan, Europe, Australia, the United States, and the Middle East. This export-oriented strategy underscores their competitive positioning in the global supply chain for specialized organic acid derivatives. Meet Changmao Biochemical Engineering's team to understand the leadership driving these manufacturing operations.

Headquartered in Changzhou, Jiangsu, China, the company is publicly traded on the HKEX under the ticker 0954.HK. Their technical expertise in biochemical engineering allows for consistent quality control across their diverse product range. By leveraging advanced manufacturing processes, the firm continues to meet the stringent regulatory requirements of international pharmaceutical and food-grade markets. The company remains committed to scaling its production capabilities while maintaining its established presence in the Asia-Pacific region and beyond.